How should the location of a uterine fibroid on the left posterior wall be recorded?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recording Location of a Left Posterior Uterine Fibroid

For a uterine fibroid on the left posterior wall, document it as "left posterior" along with its specific relationship to the myometrial layers using the FIGO classification system 1, 2, 3.

Standardized Documentation Approach

The location should be recorded systematically to ensure clear communication and treatment planning:

Essential Components to Document

1. Anatomical Position:

  • Wall location: Left posterior (as in your case)
  • Vertical position: Fundal, corporeal (body), or lower uterine segment
  • Specific examples: "left posterofundal," "left posterior corporeal," or "left posterior lower segment" 4

2. FIGO Classification (Critical for Treatment Planning):

The FIGO system describes the fibroid's relationship to the endometrium and myometrium 2, 3:

  • Type 0-2: Submucosal (extends into cavity)
  • Type 3-4: Intramural with endometrial contact
  • Type 5: Intramural (entirely within myometrium)
  • Type 6: Subserosal (>50% intramural)
  • Type 7: Subserosal (<50% intramural)
  • Type 8: Pedunculated subserosal

Your documentation should read: "Left posterior [FIGO Type X] fibroid"

Additional Required Information

Per ACR guidelines 1, imaging reports must include:

  • Size: Measure in three dimensions (length × width × height in cm)
  • Number: Total count if multiple fibroids present
  • Vascularity: Document on Doppler imaging 1
  • Distance from serosa and endometrium: Particularly important for surgical planning 3

Imaging Modality Considerations

Transvaginal ultrasound (TVUS) should be your primary documentation tool, as it provides 90-99% sensitivity for detecting fibroids 1. The combination of transabdominal and transvaginal approaches gives the most complete assessment 1, 5.

For complex cases or surgical planning, MRI with contrast provides superior characterization of location, number, and fibroid characteristics 1.

Common Documentation Pitfalls to Avoid

  • Don't use vague terms like "posterior wall fibroid" without specifying left/right and vertical position
  • Don't omit FIGO classification - this directly impacts treatment selection, particularly for minimally invasive procedures 6, 3
  • Don't forget to document relationship to adjacent structures - the cul-de-sac position is particularly relevant for posterior fibroids 5

Clinical Relevance

Posterior wall location matters because 4, 7:

  • Posterofundal fibroids are most common in the 35-44 age group
  • Posterior location may cause different pressure symptoms (rectal pressure, back pain)
  • Surgical approach differs based on anterior versus posterior location

Bottom line: Write "Left posterior [specify fundal/corporeal/lower segment] FIGO Type [X] fibroid, measuring [dimensions], with [describe vascularity]" to provide complete, standardized documentation that guides treatment decisions.

References

Guideline

acr appropriateness criteria® fibroids.

Journal of the American College of Radiology, 2022

Research

Diagnosis and classification of uterine fibroids.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2025

Guideline

acr appropriateness criteria® management of uterine fibroids: 2023 update.

Journal of the American College of Radiology, 2024

Research

Guideline No. 461: The Management of Uterine Fibroids.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.